Cargando…
Editorial Comment on Seronegative rheumatoid arthritis after combination therapy with Ipilimumab and Nivolumab for postoperative pancreatic and liver metastases from renal cell carcinoma
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978070/ https://www.ncbi.nlm.nih.gov/pubmed/36874991 http://dx.doi.org/10.1002/iju5.12574 |
| _version_ | 1784899432508030976 |
|---|---|
| author | Kurozumi, Akira |
| author_facet | Kurozumi, Akira |
| author_sort | Kurozumi, Akira |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9978070 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99780702023-03-03 Editorial Comment on Seronegative rheumatoid arthritis after combination therapy with Ipilimumab and Nivolumab for postoperative pancreatic and liver metastases from renal cell carcinoma Kurozumi, Akira IJU Case Rep Editorial Comment John Wiley and Sons Inc. 2023-01-04 /pmc/articles/PMC9978070/ /pubmed/36874991 http://dx.doi.org/10.1002/iju5.12574 Text en © 2022 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Editorial Comment Kurozumi, Akira Editorial Comment on Seronegative rheumatoid arthritis after combination therapy with Ipilimumab and Nivolumab for postoperative pancreatic and liver metastases from renal cell carcinoma |
| title | Editorial Comment on Seronegative rheumatoid arthritis after combination therapy with Ipilimumab and Nivolumab for postoperative pancreatic and liver metastases from renal cell carcinoma |
| title_full | Editorial Comment on Seronegative rheumatoid arthritis after combination therapy with Ipilimumab and Nivolumab for postoperative pancreatic and liver metastases from renal cell carcinoma |
| title_fullStr | Editorial Comment on Seronegative rheumatoid arthritis after combination therapy with Ipilimumab and Nivolumab for postoperative pancreatic and liver metastases from renal cell carcinoma |
| title_full_unstemmed | Editorial Comment on Seronegative rheumatoid arthritis after combination therapy with Ipilimumab and Nivolumab for postoperative pancreatic and liver metastases from renal cell carcinoma |
| title_short | Editorial Comment on Seronegative rheumatoid arthritis after combination therapy with Ipilimumab and Nivolumab for postoperative pancreatic and liver metastases from renal cell carcinoma |
| title_sort | editorial comment on seronegative rheumatoid arthritis after combination therapy with ipilimumab and nivolumab for postoperative pancreatic and liver metastases from renal cell carcinoma |
| topic | Editorial Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978070/ https://www.ncbi.nlm.nih.gov/pubmed/36874991 http://dx.doi.org/10.1002/iju5.12574 |
| work_keys_str_mv | AT kurozumiakira editorialcommentonseronegativerheumatoidarthritisaftercombinationtherapywithipilimumabandnivolumabforpostoperativepancreaticandlivermetastasesfromrenalcellcarcinoma |